Skip to content

Clinical trials

Cardiomyopathy, Dilated trials with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiomyopathy, Dilated Phase: Not applicable Clear all

59 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20032
20041
20074
20083
20092
20102
20115
20131
20143
20152
20163
20172
20182
20194
20207
20212
20223
20231
20244
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed27
Unknown status11
Recruiting6
Terminated5
Active, not recruiting4
Withdrawn3
Suspended1
Not yet recruiting1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Ancora Heart, Inc.3
Assistance Publique Hopitaux De Marseille2
Danish Study Group2
Imperial College London2
Institut National de la Santé Et de la Recherche Médicale, France2
LoneStar Heart, Inc.2
Stanford University2
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology2
University Hospital, Bordeaux2
University of Pennsylvania2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiomyopathy, Dilated59
Heart Failure22
Cardiomyopathies7
Cardiomyopathy, Hypertrophic6
Atrial Fibrillation2
Cardiomyopathy, Restrictive2
Coronary Disease2
Diabetes Mellitus, Type 22
Heart Diseases2
Insulin Resistance2

Trials

Showing 1 to 25 of 59. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.